Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
421 - 430 of 892 results
  • A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors | Journal of Neuroscience
    Both exogenous and endogenous cannabinoids can allosterically modulate glycine receptors (GlyRs). However, little is known about the molecular basis of cannabinoid-GlyR interactions. Here we report that sustained incubation with the endocannabinoid anandamide (AEA) substantially increased the amplitude of glycine-activated current in both rat cultured spinal neurons and in HEK-293 cells expressing human α1, rat α2 and α3 GlyRs. While the α1 and α3 subunits were highly sensitive to AEA-induced potentiation, the α2 subunit was relatively insensitive to AEA. Switching a serine at 296 and 307 in the TM3 (transmembrane domain 3) of the α1 and α3 subunits with an alanine (A) at the equivalent position in the α2 subunit converted the α1/α3 AEA-sensitive receptors to sensitivity resembling that of α2. The S296 residue is also critical for exogenous cannabinoid-induced potentiation of I Gly. The magnitude of AEA potentiation decreased with removal of either the hydroxyl or oxygen groups on AEA. While desoxy-AEA was...
    Apr 11, 2012 Wei Xiong
  • Abstract
    Effects of the FAAH inhibitor, URB597, on a visual reaction time task in rats
    Rationale: Cannabinergic compounds, such as THC and the endogenous cannabinoid, anandamide (AEA), can affect neurocognitive processes, including memory and attention. In particular, activation of cannabinoid receptors in prefrontal cortex causes deficit...
    Nov 7, 2007
  • HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses | eNeuro
    Despite the success of antiretroviral therapy in suppressing viral load, nearly half of the 37 million people infected with HIV experience cognitive and motor impairments, collectively classified as HIV-associated neurocognitive disorders (HAND). In the CNS, HIV-infected microglia release neurotoxic agents that act indirectly to elicit excitotoxic synaptic injury. HIV trans-activator of transcription (Tat) protein is one such neurotoxin that is thought to play a major role in the neuropathogenesis of HAND. The endocannabinoid (eCB) system provides on-demand neuroprotection against excitotoxicity, and exogenous cannabinoids attenuate neurotoxicity in animal models of HAND. Whether this neuroprotective system is altered in the presence of HIV is unknown. Here, we examined the effects of Tat on the eCB system in rat primary hippocampal cultures. Using whole-cell patch-clamp electrophysiology, we measured changes in retrograde eCB signaling following exposure to Tat. Treatment with Tat significantly reduced th...
    May 1, 2020 Mariah M. Wu
  • Abstract
    Lasting effects of adolescent exposure to cannabis smoke on measures of affect and cognition in rats
    Cannabis is the most widely used illicit drug in the US, and cannabis use among adolescents continues to rise. Some studies suggest that adolescent cannabis use increases the risk for depression, anxiety, and cognitive impairments later in life. In addi...
    Nov 11, 2017
  • Abstract
    Blockade of anandamide degradation increases serotonergic neuron firing activity.
    The active principle of marijuana, Δ9-tetrahydrocannabinol (THC), may regulate mood by hijacking an intrinsic cannabinoid-mediated mechanism involved in the control of emotions. In support of this hypothesis, pharmacological blockade of FAAH (fatty-acid amide hydrolase), an enzyme that hydrolyzes the endogenous cannabinoid anandamide, reduces anxiety-like behaviours in rats. These effects have not yet been identified, but they may involve activation of neurons in the dorsal raphe (DR) nucleus, a major source of serotonin in the mammalian brain. To test this possibility, we measured spontaneous firing activity in rats and mice DR neurons using in vivo recording techniques. Systemic administration of the potent and selective FAAH inhibitor URB597 (0.1 mg/kg, intravenous, i.v.) elicited a slow-onset increase in DR neuron firing, which became significant 20-140 min after drug injection (mean firing rate; vehicle: 1.45±0.1 Hz; URB597: 2.45±0.2 Hz; P < 0.01, n=55). This effect was prevented by the CB1 receptor a...
    Oct 26, 2004
  • Abstract
    Effect of neonatal maternal separation stress (NMSS) on pain threshold and neurochemical responses of colonic mucosa and spinal cord to nociceptive colonic balloon distension in adult rats.
    Eric Ziea1, Justin Wu1, Lixing Lao2, Tianhua Ren1, David Yew3, Joseph Sung1. Dept Med1, Anat3, Chin Univ Hong Kong. Center Integrat Med2, Univ Maryland,Baltimore. Childhood stress has been implicated as a contributing factor in irritable bowel syndrome(IBS).It has also been reported that neonatal maternal separation stress(NMSS) induces visceral hyperalgesia in rats, thus we used a colonic balloon distension(CBD) rat model to study the effect of NMSS on brain-gut axis neurochemical responses to nociceptive stimuli. Male neonatal SD rats were randomly divided into: 1.Maternal separation(MS;n=8) 3 hours/day on postnatal days 2-21 and 2.Non-handled control (n=8).CBD was performed on day 60 to assess abdominal withdrawal reflex (AWR),a marker of visceral pain. Pain threshold was defined as balloon pressure provoking a nociceptive AWR response to graded CBD. Substance P and serotonin (5-HT) expression along the brain-gut axis was evaluated by immunohistochemistry and ELISA.Pain threshold was significantly lower...
    Oct 24, 2004
  • Abstract
    Effects of exogenously administered cannabinoids on axonal projections of L4 neurons in the mouse barrel cortex
    Recent studies revealed that cannabinoid CB1 receptors (CB1Rs) play important roles in the development of neural circuit formation and plasticity. In the rodent barrel cortex, CB1Rs at the thalamocortical terminals causes a developmental switch from lon...
    Nov 6, 2018
  • Abstract
    Opposing roles of infralimbic and prelimbic cortices in contextual biconditional discrimination memory retrieval
    The medial prefrontal cortex (mPFC) has been widely implicated in the contextual control of appetitive and aversive conditioning. Furthermore, the two subdomains within the mPFC, the infralimbic (IL) and prelimbic (PL), have been shown to differentially...
    Nov 13, 2016
  • Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus | Journal of Neuroscience
    Endocannabinoids form a novel class of intercellular messengers, the functions of which include retrograde signaling in the brain and mediation or modulation of several types of synaptic plasticity. Yet, the signaling mechanisms and long-term effects of the stimulation of CB1 cannabinoid receptors (CB1-R) are poorly understood. We show that anandamide, 2-arachidonoyl-glycerol, and Δ9-tetrahydrocannabinol (THC) activated extracellular signal-regulated kinase (ERK) in hippocampal slices. In living mice, THC activated ERK in hippocampal neurons and induced its accumulation in the nuclei of pyramidal cells in CA1 and CA3. Both effects were attributable to stimulation of CB1-R and activation of MAP kinase/ERK kinase (MEK). In hippocampal slices, the stimulation of ERK was independent of phosphatidyl-inositol-3-kinase but was regulated by cAMP. The endocannabinoid-induced stimulation of ERK was lost in Fyn knock-out mice, in slices and in vivo , although it was insensitive to inhibitors of Src-family tyrosine ki...
    Mar 15, 2003 Pascal Derkinderen
  • Abstract
    suppression of inflammatory and neuropathic pain by CT-3: site of action and molecular mechanisms.
    1,1-Dimethylheptyl-delta-8-THC-11-oic acid (CT-3 or ajulemic acid) is a potent analog of THC-11-oic acid (the metabolite of THC). The apparent lack of psychotropic effects of CT-3 makes it an attractive candidate for therapeutic development. Here we extended the characterization of CT-3 to models of chronic inflammatory pain and neuropathic pain in rats, and investigated the mechanisms that contribute to the unique behavioral profile of CT-3. (1) Systemic administration of CT-3 was effective in suppressing thermal hyperalgesia in CFA-inflammed rats, and in reversing mechanical allodynia in the CCI model of neuropathic pain. (2) Peripheral administration of CT-3 (i.pl.) and intracerebral, but not intrathecal administration were effective in suppressing CFA-induced hyperalgesia. (3) In competition binding with [3H]SR141716A, CT-3 exhibited an approximate 4 fold higher Ki in spinal cord compared to brain membrane preparations. Likewise, in [S35]GTPgS binding assays, CT-3 behaved as a partial agonist in the br...
    Nov 5, 2002
  • Previous
  • 41
  • 42
  • 43
  • 44
  • 45
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience